{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:10:00Z","timestamp":1792789800329,"version":"4.5.0"},"reference-count":86,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T00:00:00Z","timestamp":1719705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Laon Medi Solution Inc.","award":["KDH-2023"],"award-info":[{"award-number":["KDH-2023"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>We conducted this single-center, retrospective, cohort study to examine whether insulin resistance (IR) and high-sensitivity C-reactive protein (hsCRP) have a relationship with metabolic abnormalities in patients with type 2 diabetes mellitus (T2DM). In a total of 3758 patients (n = 3758) with T2DM, we analyzed medical records and thereby evaluated their baseline characteristics such as age, sex, duration of T2DM, systolic blood pressure (SBP), diastolic blood pressure (DBP), waist circumference, body mass index (BMI), visceral fat thickness (VFT), fasting plasma insulin levels, C-peptide levels, glycated hemoglobin (HbA1c), fasting plasma glucose (FPG), postprandial plasma glucose (PPG), homeostatic model assessment of insulin resistance (HOMA-IR), homeostatic model assessment of \u03b2-cell function (HOMA-\u03b2), aspartate aminotransferase (AST), alanine aminotransferase (ALT), total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), albuminuria, intima-media thickness (IMT) and hsCRP. The patients were stratified according to the tertile of the K index of the insulin tolerance test (KITT) or hsCRP. Thus, they were divided into the lowest (\u22652.37), middle (1.54\u20132.36) and highest tertile (0\u20131.53) of KITT and the lowest (0.00\u20130.49), middle (0.50\u20131.21) and highest tertile (\u22651.22) of hsCRP. Moreover, associations of KITT and hsCRP with metabolic abnormalities, such as steatotic liver disease (SLD), metabolic syndrome (MetS), albuminuria, diabetic retinopathy and carotid atherosclerosis, were also analyzed. There was a significant positive correlation between the prevalence of SLD, MetS, albuminuria and diabetic retinopathy and KITT (p &lt; 0.001). Moreover, there was a significant positive association between the prevalence of SLD, MetS and albuminuria and hsCRP (p &lt; 0.001). In conclusion, our results indicate that clinicians should consider the relationships of IR and hsCRP with metabolic abnormalities in the management of patients with T2DM. However, further large-scale, prospective, multi-center studies are warranted to confirm our results.<\/jats:p>","DOI":"10.3390\/metabo14070371","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T09:06:07Z","timestamp":1719824767000},"page":"371","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Associations of Insulin Resistance and High-Sensitivity C-Reactive Protein with Metabolic Abnormalities in Korean Patients with Type 2 Diabetes Mellitus: A Preliminary Study"],"prefix":"10.3390","volume":"14","author":[{"given":"Yuchul","family":"Jeong","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Chungna Good Hospital, Incheon 22738, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Jun","family":"Lee","sequence":"additional","affiliation":[{"name":"St. Mary\u2019s Best ENT Clinic, Seoul 08849, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonjai","family":"Hur","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Sejong General Hospital, Bucheon 14754, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjoon","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, BS General Hospital, Incheon 23037, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se-Hyeon","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Companion Animal Industry, College of Health Science, Honam University, Gwangju 62399, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1753944717711379","article-title":"Metabolic syndrome: Pathophysiology, management, and modulation by natural compounds","volume":"11","author":"Rochlani","year":"2017","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12933-022-01560-2","article-title":"Polygenic risk for type 2 diabetes, lifestyle, metabolic health, and cardiovascular disease: A prospective UK Biobank study","volume":"21","author":"Yun","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/diabetology4020015","article-title":"Progress in Understanding Metabolic Syndrome and Knowledge of Its Complex Pathophysiology","volume":"4","author":"Jha","year":"2023","journal-title":"Diabetology"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Zhao, X., An, X., Yang, C., Sun, W., Ji, H., and Lian, F. (2023). The crucial role and mechanism of insulin resistance in metabolic disease. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1149239"},{"key":"ref_5","first-page":"884","article-title":"Non-alcoholic fatty liver disease, metabolic syndrome, and type 2 diabetes mellitus: Where do we stand today?","volume":"19","author":"Mitrovic","year":"2022","journal-title":"Arch. Med. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Vetrano, E., Rinaldi, L., Mormone, A., Giorgione, C., Galiero, R., Caturano, A., Nevola, R., Marfella, R., and Sasso, F.C. (2023). Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020468"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.2147\/DMSO.S275898","article-title":"Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications","volume":"13","author":"Wondmkun","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Chandrasekaran, P., and Weiskirchen, R. (2024). The Role of Obesity in Type 2 Diabetes Mellitus\u2014An Overview. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031882"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K.B., Ostolaza, H., and Mart\u00edn, C. (2020). Pathophysiology of Type 2 Diabetes Mellitus. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176275"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Cocea, A.-C., and Stoica, C.I. (2024). Interactions and Trends of Interleukins, PAI-1, CRP, and TNF-\u03b1 in Inflammatory Responses during the Perioperative Period of Joint Arthroplasty: Implications for Pain Management\u2014A Narrative Review. J. Pers. Med., 14.","DOI":"10.3390\/jpm14050537"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Speelman, T., Dale, L., Louw, A., and Verhoog, N.J.D. (2022). The Association of Acute Phase Proteins in Stress and Inflammation-Induced T2D. Cells, 11.","DOI":"10.3390\/cells11142163"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Badoiu, S.C., Enescu, D.M., Tatar, R., Stanescu-Spinu, I.-I., Miricescu, D., Greabu, M., Ionel, I.P., and Jinga, V. (2024). Serum Plasminogen Activator Inhibitor-1, \u03b1 1-Acid Glycoprotein, C-Reactive Protein, and Platelet Factor 4 Levels\u2014Promising Molecules That Can Complete the \u201cPuzzle\u201d of the Biochemical Milieu in Severe Burns: Preliminary Results of a Cohort Prospective Study. J. Clin. Med., 13.","DOI":"10.3390\/jcm13102794"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Boncler, M., Wu, Y., and Watala, C. (2019). The Multiple Faces of C-Reactive Protein\u2014Physiological and Pathophysiological Implications in Cardiovascular Disease. Molecules, 24.","DOI":"10.3390\/molecules24112062"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s001250051058","article-title":"Is Type II Diabetes Mellitus a Disease of the Innate Immune System?","volume":"41","author":"Pickup","year":"1998","journal-title":"Diabetologia"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s00125-005-1764-9","article-title":"An Immune Origin of Type 2 Diabetes?","volume":"48","author":"Kolb","year":"2005","journal-title":"Diabetologia"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/01.CIR.102.1.42","article-title":"Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS)","volume":"102","author":"Festa","year":"2000","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/01.CIR.0000158483.13093.9D","article-title":"Metabolic syndrome: A comprehensive perspective based on interactions between obesity, diabetes, and inflammation","volume":"111","author":"Dandona","year":"2005","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4239\/wjd.v7.i17.396","article-title":"Evidence for Current Diagnostic Criteria of Diabetes Mellitus","volume":"7","author":"Kumar","year":"2016","journal-title":"World J. Diabetes"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S1098-3597(07)80017-2","article-title":"Early Identification and Treatment of Insulin Resistance: Impact on Subsequent Prediabetes and Type 2 Diabetes","volume":"8","author":"Fonseca","year":"2007","journal-title":"Clin. Cornerstone"},{"key":"ref_21","first-page":"48","article-title":"Carotid Intima-Media Thickness and Carotid Plaque Represent Different Adaptive Responses to Traditional Cardiovascular Risk Factors","volume":"9","author":"Baroncini","year":"2015","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.3899\/jrheum.100302","article-title":"Use of Highly Sensitive C-Reactive Protein for Followup of Wegener\u2019s Granulomatosis","volume":"37","author":"Csernok","year":"2010","journal-title":"J. Rheumatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e230308","DOI":"10.1530\/JOE-23-0308","article-title":"In vivo techniques for assessment of insulin sensitivity and glucose metabolism","volume":"260","author":"Hahn","year":"2024","journal-title":"J. Endocrinol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/jch.14155","article-title":"Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension","volume":"23","author":"Minh","year":"2021","journal-title":"J. Clin. Hypertens."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/jdi.12143","article-title":"Usefulness of the Insulin Tolerance Test in Patients with Type 2 Diabetes Receiving Insulin Therapy","volume":"5","author":"Okita","year":"2014","journal-title":"J. Diabetes Investig."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1210\/jcem-68-2-374","article-title":"Estimates of in vivo insulin action in man: Comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies","volume":"68","author":"Bonora","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_27","first-page":"199","article-title":"Short Insulin Tolerance Test (SITT) for the Determination of In Vivo Insulin Sensitivity-A Comparison with Euglycemic Clamp Test","volume":"22","author":"Park","year":"1998","journal-title":"J. Korean Diabetes Assoc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.2337\/dc11-0182","article-title":"Improved Pharmacokinetic and Pharmacodynamic Profile of Rapid-Acting Insulin Using Needle-Free Jet Injection Technology","volume":"34","author":"Engwerda","year":"2011","journal-title":"Diabetes Care"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Drabsch, T., Holzapfel, C., Stecher, L., Petzold, J., Skurk, T., and Hauner, H. (2018). Associations Between C-Reactive Protein, Insulin Sensitivity, and Resting Metabolic Rate in Adults: A Mediator Analysis. Front. Endocrinol., 9.","DOI":"10.3389\/fendo.2018.00556"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"508409","DOI":"10.1155\/2015\/508409","article-title":"Mechanisms Linking Inflammation to Insulin Resistance","volume":"2015","author":"Chen","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"ref_31","first-page":"2022","article-title":"The relationship between insulin resistance, adiponectin and C-reactive protein and vascular endothelial injury in diabetic patients with coronary heart disease","volume":"16","author":"Xu","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jacc.2013.05.016","article-title":"High-sensitivity C-reactive protein and cardiovascular disease: A resolute belief or an elusive link?","volume":"62","author":"Yousuf","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1467-789x.2001.00024.x","article-title":"Insulin Resistance and Associated Metabolic Abnormalities in Muscle: Effects of Exercise","volume":"2","author":"Raynaud","year":"2001","journal-title":"Obes. Rev."},{"key":"ref_34","first-page":"1","article-title":"Metabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training","volume":"3","author":"Roberts","year":"2013","journal-title":"Compr. Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2337\/dc06-2484","article-title":"Impact of Insulin Resistance on Risk of Type 2 Diabetes and Cardiovascular Disease in People with Metabolic Syndrome","volume":"30","author":"Meigs","year":"2007","journal-title":"Diabetes Care"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Vesa, C.M., Popa, L., Popa, A.R., Rus, M., Zaha, A.A., Bungau, S., Tit, D.M., Corb Aron, R.A., and Zaha, D.C. (2020). Current Data Regarding the Relationship between Type 2 Diabetes Mellitus and Cardiovascular Risk Factors. Diagnostics, 10.","DOI":"10.3390\/diagnostics10050314"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-nutr-080508-141200","article-title":"Management of the Metabolic Syndrome and Type 2 Diabetes through Lifestyle Modification","volume":"29","author":"Magkos","year":"2009","journal-title":"Annu. Rev. Nutr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.2337\/dc09-S314","article-title":"Changing the Treatment Paradigm for Type 2 Diabetes","volume":"32","author":"Penno","year":"2009","journal-title":"Diabetes Care"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"9084","DOI":"10.3390\/cimb45110570","article-title":"The Interconnection between Hepatic Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease\u2014The Transition from an Adipocentric to Liver-Centric Approach","volume":"45","author":"Macut","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jhep.2023.08.030","article-title":"Endocrine aspects of metabolic dysfunction associated steatotic liver disease (MASLD): Beyond insulin resistance","volume":"79","author":"Hutchison","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"8377","DOI":"10.3748\/wjg.v20.i26.8377","article-title":"Non-Alcoholic Fatty Liver Disease and Diabetes: From Physiopathological Interplay to Diagnosis and Treatment","volume":"20","author":"Leite","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"20470","DOI":"10.1038\/s41598-023-47269-4","article-title":"Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population","volume":"13","author":"Zeng","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Solomon, A., Negrea, M.O., Cip\u0103ian, C.R., Boicean, A., Mihaila, R., Rezi, C., Cristinescu, B.A., Berghea-Neamtu, C.S., Popa, M.L., and Teodoru, M. (2023). Interactions between Metabolic Syndrome, MASLD, and Arterial Stiffening: A Single-Center Cross-Sectional Study. Healthcare, 11.","DOI":"10.3390\/healthcare11192696"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1038\/srep05832","article-title":"Association between Serum Free Fatty Acid Levels and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study","volume":"4","author":"Zhang","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2337\/dc16-1787","article-title":"Management of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: A Call to Action","volume":"40","author":"Bril","year":"2017","journal-title":"Diabetes Care"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1681\/ASN.2005121288","article-title":"Microalbuminuria and Risk for Cardiovascular Disease: Analysis of Potential Mechanisms","volume":"17","author":"Stehouwer","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cmet.2011.07.015","article-title":"Insulin Resistance, Hyperglycemia, and Atherosclerosis","volume":"14","author":"Bornfeldt","year":"2011","journal-title":"Cell Metab."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","article-title":"Reciprocal Relationships between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms","volume":"113","author":"Kim","year":"2006","journal-title":"Circulation"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1097\/01.ASN.0000133698.80390.37","article-title":"The Relationship between Hyperinsulinemia, Hypertension and Progressive Renal Disease","volume":"15","author":"Stas","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/MNH.0b013e32833ad5e4","article-title":"Podocytes, Glucose and Insulin","volume":"19","author":"Welsh","year":"2010","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/gfs290","article-title":"Role of Insulin Resistance in Kidney Dysfunction: Insights into the Mechanism and Epidemiological Evidence","volume":"28","author":"Menzaghi","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/MNH.0b013e32832f7002","article-title":"Role of Altered Insulin Signaling Pathways in the Pathogenesis of Podocyte Malfunction and Microalbuminuria","volume":"18","author":"Jauregui","year":"2009","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2337\/diacare.22.4.562","article-title":"Insulin Sensitivity in Subjects with Type 2 Diabetes. Relationship to Cardiovascular Risk Factors: The Insulin Resistance Atherosclerosis Study","volume":"22","author":"Haffner","year":"1999","journal-title":"Diabetes Care"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2337\/diacare.24.9.1629","article-title":"Insulin Resistance Syndrome Predicts Coronary Heart Disease Events in Elderly Type 2 Diabetic Men","volume":"24","author":"Kuusisto","year":"2001","journal-title":"Diabetes Care"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.2337\/diacare.15.12.1875","article-title":"Epidemiology of Proliferative Diabetic Retinopathy","volume":"15","author":"Klein","year":"1992","journal-title":"Diabetes Care"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1000344","DOI":"10.4172\/2155-9880.1000344","article-title":"Association between inflammatory markers and liver fat: The Multi-Ethnic Study of Atherosclerosis","volume":"5","author":"Hamirani","year":"2014","journal-title":"J. Clin. Exp. Cardiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/01.CIR.0000055014.62083.05","article-title":"C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14,719 initially healthy American women","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2337\/diabetes.52.7.1799","article-title":"Low-grade systemic inflammation and the development of type 2 diabetes: The Atherosclerosis Risk in Communities study","volume":"52","author":"Duncan","year":"2003","journal-title":"Diabetes"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2337\/diacare.23.12.1835","article-title":"Association between C-reactive protein and features of the metabolic syndrome: A population-based study","volume":"23","author":"Imhof","year":"2000","journal-title":"Diabetes Care"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/hep.20012","article-title":"A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis","volume":"39","author":"Promrat","year":"2004","journal-title":"Hepatology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jhep.2006.01.026","article-title":"Gallbladder disease is associated with insulin resistance in a high-risk Hispanic population","volume":"45","author":"Nervi","year":"2006","journal-title":"J. Hepatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: A feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1440-1746.2003.02958.x","article-title":"Non-alcoholic fatty liver syndrome: A hepatic consequence of common metabolic diseases","volume":"18","author":"Angelico","year":"2003","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.amjhyper.2005.07.026","article-title":"Diverse associations of microalbuminuria with C-reactive protein, interleukin-18, and soluble CD 40 ligand in male essential hypertensive subjects","volume":"19","author":"Tsioufis","year":"2006","journal-title":"Am. J. Hypertens."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.0000147415.40692.7f","article-title":"Low-grade inflammation and microalbuminuria in hypertension","volume":"24","author":"Pedrinelli","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.amjhyper.2004.02.008","article-title":"Inter-relationships of microalbuminuria with the other surrogates of the atherosclerotic cardiovascular disease in hypertensive subjects","volume":"17","author":"Tsioufis","year":"2004","journal-title":"Am. J. Hypertens."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1046\/j.1365-2796.2001.00914.x","article-title":"Urinary albumin excretion is independently associated with C-reactive protein levels in overweight and obese nondiabetic premenopausal women","volume":"250","author":"Pannacciulli","year":"2001","journal-title":"J. Intern. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/01.ATV.0000013786.80104.D4","article-title":"C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk","volume":"22","author":"Jager","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1053\/j.ajkd.2004.03.022","article-title":"The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: The Cardiovascular Health Study","volume":"44","author":"Barzilay","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ymthe.2020.08.017","article-title":"DPP4\/CD32b\/NF-\u03baB Circuit: A Novel Druggable Target for Inhibiting CRP-Driven Diabetic Nephropathy","volume":"29","author":"Tang","year":"2021","journal-title":"Mol. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Hart, P.C., Rajab, I.M., Alebraheem, M., and Potempa, L.A. (2020). C-Reactive Protein and Cancer-Diagnostic and Therapeutic Insights. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.595835"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/clinchem\/hvaa275","article-title":"Inflammation in Atherosclerosis-No Longer a Theory","volume":"67","author":"Libby","year":"2021","journal-title":"Clin. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/17446651.2023.2204941","article-title":"Treatment of type 2 diabetes patients with heart conditions","volume":"18","author":"Aktas","year":"2023","journal-title":"Expert. Rev. Endocrinol. Metab."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI20514","article-title":"Obesity-induced inflammatory changes in adipose tissue","volume":"112","author":"Wellen","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.diabres.2005.02.020","article-title":"C-reactive protein level as an independent risk factor of metabolic syndrome in the Korean population: CRP as risk factor of metabolic syndrome","volume":"70","author":"Lim","year":"2005","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3961\/jpmph.2008.41.6.413","article-title":"The association between circulating inflammatory markers and metabolic syndrome in Korean rural adults","volume":"41","author":"Ryu","year":"2008","journal-title":"J. Prev. Med. Public Health"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.jacc.2007.01.065","article-title":"Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people","volume":"49","author":"Ye","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2337\/diabetes.53.5.1195","article-title":"Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome","volume":"53","author":"Cheal","year":"2004","journal-title":"Diabetes"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2337\/diabetes.53.8.2087","article-title":"Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome","volume":"53","author":"Carr","year":"2004","journal-title":"Diabetes"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1475-2840-11-25","article-title":"High-sensitivity C-reactive protein to detect metabolic syndrome in a centrally obese population: A cross-sectional analysis","volume":"11","author":"Koekkoek","year":"2012","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1365-2362.32.s3.3.x","article-title":"Free fatty acids in obesity and type 2 diabetes: Defining their role in the development of insulin resistance and beta-cell dysfunction","volume":"32","author":"Boden","year":"2002","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Fahed, G., Aoun, L., Bou Zerdan, M., Allam, S., Bou Zerdan, M., Bouferraa, Y., and Assi, H.I. (2022). Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020786"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2147\/DMSO.S250699","article-title":"Anti-Lipolysis Induced by Insulin in Diverse Pathophysiologic Conditions of Adipose Tissue","volume":"13","author":"Zhao","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"11792","DOI":"10.1038\/s41598-019-48120-5","article-title":"Novel and traditional lipid profiles in Metabolic Syndrome reveal a high atherogenicity","volume":"9","author":"Paredes","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_85","first-page":"86","article-title":"Serum levels of interleukin-6 (Il-6), interleukin-18 (Il-18) and C-reactive protein (CRP) in patients with type-2 diabetes and acute coronary syndrome without ST-segment elevation","volume":"90","author":"Souza","year":"2008","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.genm.2009.02.002","article-title":"Gender differences in insulin resistance, body composition, and energy balance","volume":"6","author":"Geer","year":"2009","journal-title":"Gend. Med."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/14\/7\/371\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:08:06Z","timestamp":1760108886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/14\/7\/371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,30]]},"references-count":86,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["metabo14070371"],"URL":"https:\/\/doi.org\/10.3390\/metabo14070371","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,30]]}}}